ORIGINAL RESEARCH article
Front. Aging
Sec. Healthy Longevity
Volume 6 - 2025 | doi: 10.3389/fragi.2025.1458571
Sex differences in the association between life's essential 8 and serum anti-aging Klotho protein levels: A cross-sectional analysis in middle-aged to older adults
Provisionally accepted- 1Fifth Medical Center of the PLA General Hospital, Beijing, China
- 2Department of Endocrinology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China
- 3College of Medicine, Shantou University, Shantou, Guangdong Province, China
- 4Department of Cardiology, The First Affiliated Hospital of Shantou University Medical College, Shantou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: This study explores the association between cardiovascular health metrics (Life's Essential 8, LE8) and serum anti-aging Klotho protein levels among American adults aged 40-79, with a focus on sex-specific differences.: Utilizing data from the 2007-2016 National Health and Nutrition Examination Survey (NHANES), we applied weighted multivariable regression analyses, restricted cubic spline (RCS) modeling, and subgroup analyses to investigate the association between Life's Essential 8 (LE8) scores-including Health Behaviors and Health Factors scores-and serum Klotho concentrations, with a focus on gender differences.Results: Our study encompassed 9,534 participants, including 4,946 females and 4,588 males. Weighted multivariable regression analyses revealed that only females exhibited a positive association between Life's Essential 8 (LE8) scores and serum Klotho protein levels. Specifically, a 10-point increase in LE8 scores resulted in an elevation of Klotho levels by 17.61 pg/ml (95% CI: 9.53-25.69). Similarly, a 10-point increase in Health Behaviors scores increased Klotho levels by 5.7 pg/ml (95% CI: 0.14-11.26), and a 10-point increase in Health Factors scores was associated with a rise in Klotho levels by 14.6 pg/ml (95% CI: 7.70-21.51). Sensitivity analyses showed a significant positive trend in Klotho levels correlating with improvements in cardiovascular health (CVH) levels among females (β = 72.9, 95% CI: 35.91-109.88; p for trend < 0.001), consistent across both Health Behaviors and Health Factors scores. No similar trends were noted in males. In females, the dose-response relationship between LE8 scores and Health Factors scores displayed nonlinear patterns, whereas Health Behaviors scores showed linear patterns. Optimal threshold was identified at 65 for LE8 score. These results were consistent across various demographic and health statuses, emphasizing the sex-specific influence of LE8 scores on serum Klotho levels. This study underscores the importance of considering gender differences in cardiovascular health and its impact on anti-aging protein levels.In the present study, LE8 scores and its sub-scales were positively related to serum Klotho level in middle-aged and elderly women. This study provides new evidence of sex differences in the association between LE8 scores and serum anti-aging Klotho protein levels.
Keywords: sex differences, Life's Essential 8, Cardiovascular health, Klotho, Aging, NHANES
Received: 02 Jul 2024; Accepted: 19 May 2025.
Copyright: © 2025 Zeng, Zhang, Yang, Wang, Fan, Wang, Wang, Tang and Fang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Xuan Wang, Department of Endocrinology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100049, China
Haoxian Tang, College of Medicine, Shantou University, Shantou, 515041, Guangdong Province, China
Yi Fang, Department of Endocrinology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, 100049, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.